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INTRODUCTION
Th e incidence of chronic kidney disease (CKD) is 
increasing worldwide, with CKD being a signifi cant 
health problem associated with high morbidity, mor-
tality and costs. It is known that hypertension con-
trol is an important contributing factor in reducing 
cardiovascular risk and renal disease progression. 
Reducing protein intake in patients with CKD has a 
potential to additionally delay progression in terminal 
stage. Th ere is strong evidence supporting positive ef-
fects of replacing red meat protein with other sources 
of protein (1). Th e prevalence of type 2 diabetes and 
metabolic syndrome, alongside hypertension, are the 
main causes of CKD in Western countries, while be-
ing signifi cantly lower in vegetarian populations (2). 
Th ere is a negative relationship between components 
of plant-based diets and factors related to CKD pro-
gression such as infl ammation, uremic toxins, meta-
bolic acidosis, phosphate load, insulin resistance and 
oxidative stress (2). Th e pathophysiology of chronic 
infl ammation in CKD is the consequence of a multi-
factorial etiology. Th ere are interactions of a number 
of factors in the uremic milieu, e.g., exogenous factors 
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(dialysis membranes, central venous catheters), cellu-
lar factors (oxidative stress, cellular senescence), tissue 
factors (hypoxia, fl uid and sodium overload), microbi-
al factors (immune dysfunction, gut dysbiosis), reten-
tion of uremic toxins (advanced glycation end prod-
ucts, calciprotein particles and indoxyl sulfate) (3). All 
of the aforementioned factors interact with comorbid-
ities, superimposed acute illnesses, genetic predisposi-
tion and therapeutic interventions. Alterations of the 
gut microbial fl ora (dysbiosis) are typically found in 
patients with CKD. Th e interplay between the intes-
tinal microbiota and the kidney has been acknowl-
edged under the term ‘gut-kidney axis’ (3,4). Th e high 
concentration of ammonia is responsible for lowering 
pH in the gastrointestinal tract, which in turn  induc-
es prolonged colonic transit and dietary restrictions 
leading to decreased fi ber intake. Some medications 
such as potassium and phosphate binders, proton 
pump inhibitors, oral iron and antibiotics may under-
lie the altered composition of the intestinal microbio-
ta in uremic patients (2). Persistent systemic chronic 
infl ammation in patients with CKD contributes to a 
number of complications including arteriosclerosis, 
atherosclerosis, osteoporosis, frailty, malnutrition and 
protein wasting, metabolic syndrome and diabetes, 
malignancy and depression (5). Problems associated 
with low provider and patient awareness of kidney 
disease limit the adherence to CKD care, negatively 
aff ecting health outcomes (6). Mediterranean diet has 
been proven to prevent cardiovascular disease along-
side weight reduction due to its resemblance with diets 
proven to prevent diabetes (6). Nutrition is a common 
topic in contemporary everyday clinical medicine, not 
only in nephrology; however, awareness remains fairly 
low. Our research investigated the consequences of re-
ducing red meat intake on renal function parameters 
in CKD patients with estimated glomerular fi ltration 
rate (eGFR) >30 mLmin-11.73 m2.
PATIENTS AND METHODS 
Patients
Patients meeting biochemical criteria for CKD (two 
estimated glomerular fi ltration rates <60 mL/min/1.73 
m2 taken >90 days apart) were included. Th e eGFR 
was calculated using the Chronic Kidney Disease Ep-
idemiology Collaboration (CKD-EPI) formula. Blood 
pressure (BP) was measured twice in the sitting posi-
tion using a BP Monitor with Stroke Risk Detection 
(Microlife, with a conical cuff  fi tting normal and large 
arms). Resistant hypertension was defi ned as BP at 
goal with 4 full-dose drugs. A total of 46 overweight 
RH ND-CKD patients with mildly or moderately de-
creased renal function (eGFR <60 mLmin-11.73 m2) 
were included and followed for 6 months (age 66±9 
years, 19M/27F, serum creatinine 90±17 μmol/L). Pa-
tients were divided into two groups: group A was put 
on a special diet (reduction of red meat intake to 2x 
weekly and adding 50% more vegetables to the diet 
with 8-hour time restricted feeding); group B had no 
reduction of red meat intake alongside consuming less 
vegetable and without time restricted feeding. A food 
frequency questionnaire was used to collect informa-
tion on the consumption of food at home, as well as 
the number of servings consumed (<3 or >3). Th ere 
were no diff erences in renal function, cholesterol, 
triglycerides, fasting glucose, age, sex, duration and 
therapy of hypertension between the groups, and con-
stipation. Constipation was defi ned as a condition of 
the digestive system in which an individual has hard 
feces that is diffi  cult to expel (yes or no). Th e poten-
tial hyperkalemia risk of increasing fruit and vegetable 
intake in group A was also investigated. Patients were 
evaluated at the beginning and aft er 6 months of man-
agement. 
Exclusion criteria were patients with kidney trans-
plantation and history of any gastrointestinal infl am-
matory disease, heart failure patients, sign of anemia 
or infl ammation (measured with C-reactive protein 
(CRP) or highly sensitive CRP (hsCRP) >5 mg/L). Pa-
tients taking drugs such as oral anticoagulation ther-
apy (OACs) were excluded (vitamin K antagonists). 
Th e eGFR was checked at the beginning and aft er 6 
months in both groups. Th e study was conducted 
between January and July 2017. Th is study was con-
ducted in accordance with the amended Declaration 
of Helsinki. Th e study was approved by the hospital 
Ethics Committee and all participants submitted their 
informed written consent.
Statistical analysis
Data were processed using the SPSS soft ware. Statisti-
cal data analysis was performed using descriptive sta-
tistics. Continuous variables were presented as mean 
and standard deviation. Categorical variables were 
presented as percentage. Paired sample t-test was ap-
plied for comparison of results. Th e level of statistical 
signifi cance was set at p<0.05.
RESULTS
A cohort of 46 ND-CKD patients showed that 58.7% 
of available patients were female (F=27). Th e majority 
of patients were in the >55 age group (65%). Th e pri-
mary endpoint was to evaluate the effi  cacy and safety 
of twice-a-week red meat intake, while also adding 
50% more vegetables to the diet alongside 8-hour time 
restricted feeding in ND-CKD patients. Th ere were no 
statistically signifi cant diff erences in laboratory values 
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between the groups of patients stratifi ed according to 
primary kidney disease, age and sex. Treatment with a 
specialized diet (group A, 69% F) caused a decrease in 
body mass index (BMI) from 36.4±5.1 kg/m2 to 33±5 
kg/m2, body weight from 112±13 kg to 106±18 kg, and 
waist circumference from 119±11 cm to 112±10 cm 
(p<0.05). Additionally, the 6-month administration 
of the specialized diet caused a signifi cant decrease in 
the offi  ce systolic blood pressure (SBP, from 147±15 
to 140±12 mm Hg (p<0.05). However, diastolic BP 
(from 89±8 to 86±6 mm Hg) and HR (from 79±10 to 
77±11 beats/min (p=0.9)) did not change signifi cantly 
(p=0.01)). Th e 6-month administration of a special-
ized diet did not cause a decrease of eGFR (from 43±13 
mLmin-11.73 m2 to 45±14 mLmin-11.73 m2 (p=0.01). 
In group B (69.6% M), eGFR decreased from 43±11 
mLmin-11.73 m2 to 41.2±13 mLmin-11.73 m2 (p=0.01), 
BMI changed from 35.2±4.1 kg/m2 to 34.8±5.2 kg/
m2, weight from 110±11 kg to 109±13 kg, and waist 
circumference from 116±12 cm to 115±10 cm. How-
ever, during the 6 months of the study, a decrease in 
BP (SBP, from 146±11 to 144±12 mm Hg and DBP 
from 86±8 to 85±6 mm Hg (p=0.01)) and HR (from 
77±11 to 76±10 beats/min (p=0.9)) was not found to 
be signifi cant.
Th e food frequency questionnaire with information 
on the consumption of foods at home and the number 
of servings consumed showed that 80% of group A pa-
tients had >3 consumptions/day, whereas in group B 
there were 70% of patients with <3 consumptions/day. 
Aft er 6 months, the mean GFR in group A was 45.2±14 
mL/min/1.73 m², while in group B it was 41.2±11 mL/
min/1.73 m². Th e mean eGFR was lower in group B 
than in group A aft er 6 months, which was statistically 
signifi cant (p<0.05). During the study, none of the pa-
tients suff ered adverse events such as hypertensive or 
hypotensive episode, including acidosis or potassium 
>5.1 mmol/L. 
At the end of the study, answer to the question wheth-
er patients had problems with constipation was yes in 
14% of group A patients and 75% in group B patients 
(p<0.05).
Clinical follow-up aft er 2 months revealed that two fe-
male patients from group B contracted urinary tract 
infections, and one group B patient had atrial fi brilla-
tion. None of the group A patients had deterioration 
of kidney function aft er the end of the study, while 
50% of group A patients continued to follow a similar 
diet with less red meat.
DISCUSSION 
For more than a century, quantitative reduction of di-
etary protein intake has been recognized as a thera-
peutic option in patients with chronic kidney disease. 
Th e relationship between dietary protein sources and 
the risk of incident kidney disease and its progres-
sion has long been neglected. Nearly one half of all 
deaths from heart disease, stroke, and type 2 diabetes 
(cardiometabolic deaths) among adults in the United 
States were found to be associated with suboptimal 
intake of fruits, vegetables, nuts, seeds, and omega-3 
fatty acids (1). Results from diff erent studies confi rm a 
kidney-protective eff ect of plant-based diets in the pri-
mary and secondary prevention of CKD progression 
(5). Wang et al. showed that hsCRP and interleukin-6 
levels were signifi cantly higher in patients with bacte-
rial DNA than those without it, and bacterial translo-
cation occurs in patients with fi nal stage chronic kid-
ney disease and is associated with microinfl ammation 
(5). Studies have determined the nutritional safety of 
plant-based diets in CKD patients, despite the combi-
nation of a varying dietary protein restriction. As ob-
served in the healthy population, this dietary pattern 
is associated with a reduced risk of all-cause mortality 
in patients with kidney disease (6). Accumulation of 
uremic toxins is associated with an increased risk of 
CKD progression (7). Some uremic toxins are a result 
of nutrient processing by gut microbiota and serve as 
precursors of uremic toxins such as indoxyl sulfate 
and indole-3 acetic acid, trimethylamine N-oxide 
(TMAO) and p-cresyl sulfate (7). Increased intake of 
some nutrients may modify the gut microbiota and 
increase the number of bacteria that process them 
to uremic toxins and increased risk of CKD progres-
sion. It is an opportunity for therapeutic intervention 
by modifying the diet, modifying the microbiota, in-
creasing toxin excretion, decreasing uremic toxin pro-
duction by microbiota and targeting specifi c uremic 
toxins. Specifi c focus will be placed on the decreased 
availability of bacteria-derived metabolites with ne-
phroprotective potential, such as vitamin K (therapy 
with warfarin induces defi ciency of vitamin K) and 
butyrate and the cellular and molecular mechanisms 
linking these uremic toxins and protective factors to 
kidney diseases (7). Th is allows the development of 
novel therapeutic approaches. Th e US Department of 
Agriculture (USDA) replaced food pyramids with My-
Plate in 2011 (8). Th e plate is divided into four, roughly 
equal parts: fruits, vegetable, grains, and proteins. Th e 
plate is a reminder of how to eat healthier. Beside the 
plate is the fi ft h food group, dairy, positioned as a bev-
erage. Dairy can be cheese, or yogurt, a glass of milk or 
can be substituted with a fortifi ed soy-based beverage 
(8). Prebiotics should be an integral part of a healthy 
diet, and dietary fi ber is the best-known prebiotic. Fi-
bers are found in vegetables and fruits, legumes, nuts, 
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as well as whole and fi ber-enriched grains, keeping di-
gestion moving, binding cholesterol, and pushing out 
carcinogens (9). Prebiotics balance the composition 
and activity of the gut fl ora to benefi t health. Th e con-
sumption of dietary fi ber is linked to improved cardio-
vascular health, lower body weight and can help with 
issues of gastrointestinal motility (9). Diets that pro-
mote weight loss include increased consumption of 
vegetables, fruits, and high-fi ber, whole-grain foods, 
increased intake of water; and reduced consumption 
of dietary sugar and sugar-sweetened beverages. Spe-
cifi c diets include the Dietary Approaches to Stop Hy-
pertension (DASH) diet and the Mediterranean diet, 
which has been correlated with lower risks of cardio-
vascular disease, cancers, obesity, diabetes type 2, Par-
kinson disease/cognitive health and death (4). Dietary 
management of CKD patients focuses on the quantity 
of energy and protein with little mention of dietary 
quality. Dietary patterns that are lower in meat, so-
dium and refi ned sugar and more plant-based with a 
higher content of fi ber and grains are more important 
for chronic disease prevention. Th e potential hyperka-
lemia risk of increasing fruit and vegetable intake in 
diet was not detected. Increase in fi ber consumption 
seen in group A leads to better control of constipation 
without metabolic acidosis. Th e specialized diet has 
favorable eff ects on systolic blood pressure, obesity, 
and explains the reduced renal function decline ob-
served in non-dialysis CKD patients adhering to diet 
with less red meat (twice a week) plus 50% more veg-
etables and 8-hour time restricted feeding. Nutrition 
plays a key role in managing patients with kidney dis-
ease. Patients with CKD are at a high risk of protein 
energy wasting (PEW) defi ned as a condition of un-
dernutrition and increased catabolism. Th e prevalence 
of PEW is 15% to 18% in predialysis CKD. Reduction 
in kidney function is associated with an infl ammatory 
response. Ketoanalog supplemented very low protein 
diet in predialysis CKD should be considered as one of 
the main approaches in the management program to 
prevent malnutrition and slow progression of disease 
(10).
Research by Gabel et al. showed that 12 weeks of 
time-restricted feeding in which an obese person had 
8 hours of unrestricted eating followed by 16 hours of 
water fasting, resulted in mild calorie restriction and 
may help with weight loss and blood pressure control 
(11). In our study, we showed that intermittent fasting 
could be of benefi t to CKD patients. Dietary restric-
tion of protein intake has been proposed as a possible 
kidney-protective treatment.
Many points still need to be addressed for CKD pa-
tients, e.g., which diet should be recommended for 
patients with kidney disease, and which for CKD pa-
tients with prediabetes and diabetes. Can we prevent 
CKD by means of a diet with replacement of red meat 
protein? Is there any additive eff ect of such a diet and 
exercise in CKD prevention? Th e plant-based diets 
should be included as part of the clinical recommen-
dations in predialysis or ND-CKD patients.
LIMITATIONS OF THE STUDY
Th e limitation of this study was that we had no data on 
serum albumin and levels of hsCRP in order to con-
clude about malnutrition and infl ammation. Patients 
in this study did not take Keto/Amino Acid-Supple-
mented protein-Restricted Diets. 
CONCLUSION
Th e fi ndings of this study suggest there is an associ-
ation between the consumption of red meat and the 
risk of progression of CKD. Th e 6-month adminis-
tration of the diet proved to be useful in slowing the 
progression of CKD (via interaction with acidifi cation 
in the kidney), resulting in signifi cant additional re-
duction in SBP, possibly via interaction with the au-
tonomic nervous system. Th e plant-based diets in the 
future should be included as part of the recommenda-
tions for the prevention and management of CKD in 
everyday clinical practice. 
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U prospektivnoj studiji ispitan je utjecaj promjene prehrambenih navika u bolesnika s kroničnom bubrežnom bolesti u pred-
dijaliznoj fazi. U 46 bolesnika s rezistentnom hipertenzijom tijekom 6 mjeseci crveno je meso zamijenjeno drugom vrstom 
proteina biljnog podrijetla (19 M/27 Ž; srednje dobi 66±9 godina, eGFR 43±12 mL/min-11,73 m2). Bolesnici su podijeljeni u 
dvije skupine: skupina A je imala dijetu koja je uključivala redukciju unosa crvenog mesa na samo 2 puta/tjedan, povećan 
je unos povrća na 50 % više nego prethodno, uz 8-satno razdoblje bez uzimanja hrane. Skupina B nije mijenjala postojeće 
prehrambene navike. Koristili smo upitnik o broju obroka kao i o vrsti uzimanja proteina. U razdoblju praćenja nije bilo 
neželjenih događaja, a u skupini A u odnosu na skupinu B postignuta je značajna redukcija tlaka, težine i opsega struka: 
BMI s 36,4±5,1 na 33±5 kg/m2, tjelesna težina sa 112±13 na 106±18 kg, opseg struka sa 119±11 na 112±10 cm, sniženje 
sistoličkog krvnog tlaka sa 147±15 na 140±12 mm Hg (p<0,05). Sniženje dijastoličkog tlaka nije bilo statistički značajno (s 
89±8 na 86±6 mm Hg (p=0,1)) kao ni frekvencije (sa 79±10 na 77±11/min (p=0,9)) u objema skupinama. Bubrežna funkcija 
procijenjena pomoću eGFR nakon 6 mjeseci bila je statistički značajna: u skupini A bila je 45,2±14 mL/min/1,73m², a u sku-
pini B 41,2±11 mL/min/1,73m² (p<0,05). Prehrana sa sniženim unosom proteina životinjskog podrijetla uz dodatak proteina 
biljnog podrijetla te pridržavanje 8-satnog neuzimanja hrane usporava progresiju kronične bubrežne bolesti u bolesnika u 
preddijalizi.
Ključne riječi: prehrana, kronična bubrežna bolest 
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